Role of bridging therapy during chimeric antigen receptor T cell therapy

por Bhaskar, Shakthi T., Dholaria, Bhagirathbhai R., Sengsayadeth, Salyka M., Savani, Bipin N., Oluwole, Olalekan O.
Publicado 2021

Artificial intelligence modelling to assess the risk of cardiovascular disease in oncology patients

por Al-Droubi, Samer S, Jahangir, Eiman, Kochendorfer, Karl M, Krive, Marianna, Laufer-Perl, Michal, Gilon, Dan, Okwuosa, Tochukwu M, Gans, Christopher P, Arnold, Joshua H, Bhaskar, Shakthi T, Yasin, Hesham A, Krive, Jacob
Publicado 2023

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

por Bhaskar, Shakthi T., Patel, Vivek G., Porter, David L., Schuster, Stephen J., Nastoupil, Loretta J., Perales, Miguel-Angel, Tomas, Ana Alarcon, Bishop, Michael R., McGuirk, Joseph P., Maziarz, Richard T., Chen, Andy I., Bachanova, Veronika, Maakaron, Joseph E., Riedell, Peter A., Oluwole, Olalekan O.
Publicado 2022